top of page
Search

Unveiling Groundbreaking Research at the AD/PD International Conference



We are thrilled to share exciting news from the heart of our research endeavors! Starlab Barcelona is set to make a significant mark at the AD/PD International Conference on Alzheimer's and Parkinson's diseases, scheduled from March 5th to 9th. This event serves as the platform for revealing the preliminary results of our latest study, which focuses on the application of EEG biomarkers for the early detection of Alzheimer's disease.


Delving into the Dynamics of Brain Activity during Healthy Aging

In this groundbreaking study, we embarked on a comprehensive exploration of the intricate changes in brain activity that occur during the process of healthy aging. Our dataset, drawn from a diverse cohort of 195 healthy individuals spanning ages 18 to 85, provided the foundation for comparison with 161 participants aged 60-85, exhibiting symptoms or potential indicators of cognitive decline.


Of particular significance were the subgroups diagnosed with Alzheimer's disease (AD, N=48), Mild Cognitive Impairment (MCI, N=79), and Subjective Cognitive Decline (SCD, N=34). Notably, SCD, characterized by self-perceived cognitive decline not reflected in conventional tests, emerged as a potential target for early intervention trials.


Groundbreaking Findings: Unraveling the Complexity of Alzheimer's

Our research uncovered compelling insights. While Alzheimer's disease showcased widespread alterations in brain activity across the entire scalp, MCI, and a substantial portion of SCD individuals exhibited these changes primarily in posterior areas. Early recognition is paramount for implementing effective strategies and tools, enhancing the independence of those affected.


A Major Milestone for Starlab and Society

This achievement represents a significant milestone for Starlab and society at large, marking a united front against Alzheimer's disease. Together, we stand to benefit from these game-changing results, fostering innovation in the fields of research, neuroscience, and beyond.

Comments


bottom of page